{
    "summary": "The 'Plain Prescription Prices Act' (H.R. 4623) mandates that direct-to-consumer advertisements for prescription drugs and biological products on television include truthful and non-misleading pricing information. This requirement applies to drugs and products for which payment is available under Medicare and Medicaid. The Secretary of Health and Human Services, through the Centers for Medicare & Medicaid Services, is tasked with creating regulations detailing the format, enforcement mechanisms, and whether other price information should be included.",
    "tags": [
        "Healthcare",
        "Consumer protection",
        "Transparency",
        "Healthcare access"
    ],
    "category": "Healthcare & Public Health"
}